
Somatostatin Analogs Global Market Report 2025
Description
Somatostatin Analogs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on somatostatin analogs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for somatostatin analogs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The somatostatin analogs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Type: Octreotide; Lanreotide; Pasireotide
2) By Treatment: Acromegaly; Cushing’s Syndrome; Neuroendocrine Tumors; Carcinoid Syndrome; Other Treatments
3) By End User: Hospital; Pharmaceutical Companies
Subsegments:
1) By Octreotide: Long-Acting Release (LAR) Formulations; Short-Acting Formulations
2) By Lanreotide: Depot Formulations; Injectable Formulations
3) By Pasireotide: Long-Acting Injectable Formulations; Subcutaneous Formulations
Companies Mentioned: Novartis International AG; Pfizer Inc.; Sun Pharmaceutical Industries Limited; Midatech Pharma plc; Crinetics Pharmaceuticals Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on somatostatin analogs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for somatostatin analogs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The somatostatin analogs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Octreotide; Lanreotide; Pasireotide
2) By Treatment: Acromegaly; Cushing’s Syndrome; Neuroendocrine Tumors; Carcinoid Syndrome; Other Treatments
3) By End User: Hospital; Pharmaceutical Companies
Subsegments:
1) By Octreotide: Long-Acting Release (LAR) Formulations; Short-Acting Formulations
2) By Lanreotide: Depot Formulations; Injectable Formulations
3) By Pasireotide: Long-Acting Injectable Formulations; Subcutaneous Formulations
Companies Mentioned: Novartis International AG; Pfizer Inc.; Sun Pharmaceutical Industries Limited; Midatech Pharma plc; Crinetics Pharmaceuticals Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Somatostatin Analogs Market Characteristics
- 3. Somatostatin Analogs Market Trends And Strategies
- 4. Somatostatin Analogs Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
- 5. Global Somatostatin Analogs Growth Analysis And Strategic Analysis Framework
- 5.1. Global Somatostatin Analogs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Somatostatin Analogs Market Growth Rate Analysis
- 5.4. Global Somatostatin Analogs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Somatostatin Analogs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Somatostatin Analogs Total Addressable Market (TAM)
- 6. Somatostatin Analogs Market Segmentation
- 6.1. Global Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Octreotide
- Lanreotide
- Pasireotide
- 6.2. Global Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Acromegaly
- Cushing’s Syndrome
- Neuroendocrine Tumors
- Carcinoid Syndrome
- Other Treatments
- 6.3. Global Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital
- Pharmaceutical Companies
- 6.4. Global Somatostatin Analogs Market, Sub-Segmentation Of Octreotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Long-Acting Release (LAR) Formulations
- Short-Acting Formulations
- 6.5. Global Somatostatin Analogs Market, Sub-Segmentation Of Lanreotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Depot Formulations
- Injectable Formulations
- 6.6. Global Somatostatin Analogs Market, Sub-Segmentation Of Pasireotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Long-Acting Injectable Formulations
- Subcutaneous Formulations
- 7. Somatostatin Analogs Market Regional And Country Analysis
- 7.1. Global Somatostatin Analogs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Somatostatin Analogs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Somatostatin Analogs Market
- 8.1. Asia-Pacific Somatostatin Analogs Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Somatostatin Analogs Market
- 9.1. China Somatostatin Analogs Market Overview
- 9.2. China Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Somatostatin Analogs Market
- 10.1. India Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Somatostatin Analogs Market
- 11.1. Japan Somatostatin Analogs Market Overview
- 11.2. Japan Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Somatostatin Analogs Market
- 12.1. Australia Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Somatostatin Analogs Market
- 13.1. Indonesia Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Somatostatin Analogs Market
- 14.1. South Korea Somatostatin Analogs Market Overview
- 14.2. South Korea Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Somatostatin Analogs Market
- 15.1. Western Europe Somatostatin Analogs Market Overview
- 15.2. Western Europe Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Somatostatin Analogs Market
- 16.1. UK Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Somatostatin Analogs Market
- 17.1. Germany Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Somatostatin Analogs Market
- 18.1. France Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Somatostatin Analogs Market
- 19.1. Italy Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Somatostatin Analogs Market
- 20.1. Spain Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Somatostatin Analogs Market
- 21.1. Eastern Europe Somatostatin Analogs Market Overview
- 21.2. Eastern Europe Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Somatostatin Analogs Market
- 22.1. Russia Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Somatostatin Analogs Market
- 23.1. North America Somatostatin Analogs Market Overview
- 23.2. North America Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Somatostatin Analogs Market
- 24.1. USA Somatostatin Analogs Market Overview
- 24.2. USA Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Somatostatin Analogs Market
- 25.1. Canada Somatostatin Analogs Market Overview
- 25.2. Canada Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Somatostatin Analogs Market
- 26.1. South America Somatostatin Analogs Market Overview
- 26.2. South America Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Somatostatin Analogs Market
- 27.1. Brazil Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Somatostatin Analogs Market
- 28.1. Middle East Somatostatin Analogs Market Overview
- 28.2. Middle East Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Somatostatin Analogs Market
- 29.1. Africa Somatostatin Analogs Market Overview
- 29.2. Africa Somatostatin Analogs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Somatostatin Analogs Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Somatostatin Analogs Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Somatostatin Analogs Market Competitive Landscape And Company Profiles
- 30.1. Somatostatin Analogs Market Competitive Landscape
- 30.2. Somatostatin Analogs Market Company Profiles
- 30.2.1. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Midatech Pharma plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Crinetics Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Somatostatin Analogs Market Other Major And Innovative Companies
- 31.1. Peptron Inc.
- 31.2. Teva Pharmaceutical Industries Ltd.
- 31.3. Camurus AB
- 31.4. Bayer Aktiengesellschaft
- 31.5. Cadila Healthcare Limited
- 31.6. Amneal Pharmaceuticals Inc.
- 31.7. Recordati S.p.A.
- 31.8. Amryt Pharma plc
- 31.9. Ipsen Pharma SA
- 31.10. Fresenius Kabi AG
- 31.11. Chiasma Inc.
- 31.12. Merck KGaA
- 31.13. Sanofi S.A.
- 31.14. Sandoz International GmbH
- 31.15. Takeda Pharmaceutical Company Limited
- 32. Global Somatostatin Analogs Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Somatostatin Analogs Market
- 34. Recent Developments In The Somatostatin Analogs Market
- 35. Somatostatin Analogs Market High Potential Countries, Segments and Strategies
- 35.1 Somatostatin Analogs Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Somatostatin Analogs Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Somatostatin Analogs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.